Comparative efficacy of eritoran, a toll-like receptor 4 antagonist, in patients with severe sepsis and higher risk of mortality by type of causative pathogen
Author Department
Medicine
Document Type
Presentations, Research
Publication Date
1-1-2010
Recommended Citation
LaRosa S, Tidswell M. Comparative efficacy of eritoran, a toll-like receptor 4 antagonist, in patients with severe sepsis and higher risk of mortality by type of causative pathogen. Society of Critical Care Medicine Critical care Congress. San Diego, CA. 2010.
COinS